T A McDonagh

Summary

Affiliation: University of Glasgow
Country: UK

Publications

  1. ncbi Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population
    T A McDonagh
    Department of Medical Cardiology, University of Glasgow, Royal Infirmary, 10 Alexandra Parade, Glasgow G31 2ER, UK
    Heart 86:21-6. 2001
  2. ncbi NT-proBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studies
    T A McDonagh
    Department of Cardiology, Royal and Western Infirmaries, University of Glasgow, 10 Alexandra Parade, Glasgow, Scotland G31 2ER, UK
    Eur J Heart Fail 6:269-73. 2004
  3. ncbi Screening for left ventricular dysfunction: a step too far?
    T A McDonagh
    Department of Medical Cardiology, University of Glasgow, Glasgow Royal Infirmary, 10 Alexandra Parade, Glasgow G31 2ER, UK
    Heart 88:ii12-4. 2002
  4. ncbi ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects
    D R Murdoch
    Department of Cardiology, Western Infirmary, Glasgow, UK
    Am Heart J 141:800-7. 2001
  5. ncbi The prognostic use of right heart catheterization data in patients with advanced heart failure: how relevant are invasive procedures in the risk stratification of advanced heart failure in the era of neurohormones?
    R S Gardner
    Department of Cardiology, University of Glasgow, Glasgow, UK
    J Heart Lung Transplant 24:303-9. 2005
  6. ncbi N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure
    R S Gardner
    The Scottish Cardiopulmonary Transplant Unit, Glasgow Royal Infirmary, Glasgow, UK
    Eur Heart J 24:1735-43. 2003
  7. ncbi Asymptomatic left ventricular dysfunction in the community
    T A McDonagh
    Department of Medical Cardiology, University of Glasgow Royal Infirmary, 10 Alexandra Parade, Glasgow, G31 6ER, Scotland t
    Curr Cardiol Rep 2:470-4. 2000
  8. ncbi Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy
    D R Murdoch
    Clinical Research Initiative in Heart Failure, West Medical Building, University of Glasgow, Scotland
    Am Heart J 138:1126-32. 1999
  9. ncbi The prevalence of haemochromatosis gene mutations in the West of Scotland and their relation to ischaemic heart disease
    S Campbell
    Department of Gastroenterology, Gartnavel General Hospital, Glasgow, UK
    Heart 89:1023-6. 2003
  10. ncbi Morphine for the relief of breathlessness in patients with chronic heart failure--a pilot study
    M J Johnson
    West of Scotland Rotation, Glasgow, UK
    Eur J Heart Fail 4:753-6. 2002

Collaborators

Detail Information

Publications16

  1. ncbi Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population
    T A McDonagh
    Department of Medical Cardiology, University of Glasgow, Royal Infirmary, 10 Alexandra Parade, Glasgow G31 2ER, UK
    Heart 86:21-6. 2001
    ....
  2. ncbi NT-proBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studies
    T A McDonagh
    Department of Cardiology, Royal and Western Infirmaries, University of Glasgow, 10 Alexandra Parade, Glasgow, Scotland G31 2ER, UK
    Eur J Heart Fail 6:269-73. 2004
    ..An elevated NT-proBNP merely indicates the presence of 'cardio-renal distress' and should prompt referral for further investigation...
  3. ncbi Screening for left ventricular dysfunction: a step too far?
    T A McDonagh
    Department of Medical Cardiology, University of Glasgow, Glasgow Royal Infirmary, 10 Alexandra Parade, Glasgow G31 2ER, UK
    Heart 88:ii12-4. 2002
  4. ncbi ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects
    D R Murdoch
    Department of Cardiology, Western Infirmary, Glasgow, UK
    Am Heart J 141:800-7. 2001
    ..When added to ACE inhibitors, angiotensin II type 1 (AT1) antagonists may allow more complete blockade of the RAAS and preserve the beneficial effects of bradykinin accumulation not seen with AT1 receptor blockade alone...
  5. ncbi The prognostic use of right heart catheterization data in patients with advanced heart failure: how relevant are invasive procedures in the risk stratification of advanced heart failure in the era of neurohormones?
    R S Gardner
    Department of Cardiology, University of Glasgow, Glasgow, UK
    J Heart Lung Transplant 24:303-9. 2005
    ..This study reconsiders the use of right heart catheterization data and compares their use to that of N-terminal pro-brain natriuretic peptide (NT-proBNP), a neurohormone linked with prognosis in chronic heart failure...
  6. ncbi N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure
    R S Gardner
    The Scottish Cardiopulmonary Transplant Unit, Glasgow Royal Infirmary, Glasgow, UK
    Eur Heart J 24:1735-43. 2003
    ..The purpose of this study was to examine the prognostic ability of NT-proBNP in advanced heart failure and compare it to that of the LVEF, peak VO2 and the HFSS...
  7. ncbi Asymptomatic left ventricular dysfunction in the community
    T A McDonagh
    Department of Medical Cardiology, University of Glasgow Royal Infirmary, 10 Alexandra Parade, Glasgow, G31 6ER, Scotland t
    Curr Cardiol Rep 2:470-4. 2000
    ..As such it has the potential to be a cost-effective means of filtering subjects suspected of having LVD and allowing more appropriate use of tertiary referrals for specialist assessment and detailed echocardiography...
  8. ncbi Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy
    D R Murdoch
    Clinical Research Initiative in Heart Failure, West Medical Building, University of Glasgow, Scotland
    Am Heart J 138:1126-32. 1999
    ..We sought to determine whether titration of vasodilator therapy according to plasma brain natriuretic peptide (BNP) concentration may be of value in the individual optimization of vasodilator therapy in CHF...
  9. ncbi The prevalence of haemochromatosis gene mutations in the West of Scotland and their relation to ischaemic heart disease
    S Campbell
    Department of Gastroenterology, Gartnavel General Hospital, Glasgow, UK
    Heart 89:1023-6. 2003
    ..This study aims to determine whether the two major mutations of the haemochromatosis (HFE) gene (C282Y and H63D) are associated with ischaemic heart disease (IHD) or myocardial infarction (MI)...
  10. ncbi Morphine for the relief of breathlessness in patients with chronic heart failure--a pilot study
    M J Johnson
    West of Scotland Rotation, Glasgow, UK
    Eur J Heart Fail 4:753-6. 2002
    ..Morphine has long been used to relieve symptoms in acute failure, but there is little evidence about this potentially useful palliative therapy in CHF...
  11. ncbi Validation of an echocardiographic wall motion index in heart failure due to ischaemic heart disease
    J H McGowan
    Department of Medical and Nuclear Cardiology, Glasgow Royal Infirmary, G31 2ER, Glasgow, UK
    Eur J Heart Fail 3:731-7. 2001
    ..This study aimed to examine the application of a wall motion index (WMI) method, using a nine-segment LV model in patients with chronic heart failure (CHF) due to IHD...
  12. ncbi Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema; effects on plasma brain natriuretic peptide concentrations
    C A Kelly
    Department of Respiratory Medicine, Royal Infirmary, Edinburgh, Scotland, UK
    Eur Heart J 23:1379-86. 2002
    ..CPAP is a useful adjunctive treatment in the early management of acute heart failure...
  13. ncbi Lessons from the management of chronic heart failure
    T A McDonagh
    Royal Brompton and Harefield NHS Trust, Sydney Street, London SW3 6NP, UK
    Heart 91:ii24-7; discussion ii31, ii43-8. 2005
    ..Applying such an approach to the care of the post-MI heart failure patient should be equally important...
  14. ncbi Importance of beta blockade in the treatment of advanced heart failure
    R S Gardner
    Heart 89:1442-4. 2003
  15. ncbi The treatment of chronic heart failure due to left ventricular systolic dysfunction
    R S Gardner
    Department of Cardiology, Monklands Hospital, Airdrie
    Clin Med 4:18-22. 2004
  16. ncbi N-terminal brain natriuretic peptide is predictive of death after cardiac transplantation
    R S Gardner
    Heart 92:121-3. 2006